Where does bit.bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across bit.bio's 1 recorded funding rounds.

Premier Alternatives

bit.bio

Biotechnology · Cambridge, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a synthetic biology platform designed to provide human cells for research, drug discovery and cell therapy. bit.bio is based in Cambridge, United Kingdom and was founded in 2016. It was valued at $546 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $234 million across 1 recorded round; the latest was a $138 million later-stage round in Dec 2021.

PMV mark · valuation

$546.3M

Oct 2026

Priced at

its later-stage round

Dec 2021

Total raised

$234.2M

Last round

Later Stage VC

Dec 2021

Cap table — not yet on record

bit.bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of bit.bio with a free account

·The complete investor list: 35 names
·Watch bit.bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about bit.bio

Where does bit.bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across bit.bio's 1 recorded funding rounds.